ArticleFrontiers in public health2022
Social prescribing for frequent attenders in primary care: An economic analysis.
Article in Frontiers in public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- Systematic literature review of economic studies on nature-based social prescribing for health improvement.BMC primary care · 2026Pooled it
- Social prescribing outcomes: a mapping review of the evidence from 13 countries to identify key common outcomes.Frontiers in medicine · 2023Pooled it
- Examining Psychosocial and Economic Barriers to Green Space Access for Racialised Individuals and Families: A Narrative Literature Review of the Evidence to Date.International journal of environmental research and public health · 2022Pooled it
- Evaluating the social return on investment of nature-based social prescribing to alleviate loneliness: a randomized controlled trial in Barcelona.Frontiers in public health · 2026Trial
- 'So, this feels very different and, you know, kindly': a mixed methods study of arts on prescription in secondary care.European journal of public health · 2026Article
- High Utilisation Behaviour in Emergency Departments: Predictors in Baixo Alentejo Region.Portuguese journal of public health · 2026Article
- Changes in mental health during participation in Art Pharmacy: a longitudinal study of a U.S. arts-based social prescribing program.Frontiers in public health · 2026Article
- Art for health's sake or health for art's sake: Disentangling the bidirectional relationships between arts engagement and mental health.PNAS nexus · 2024Article
- Stakeholder views on addressing challenges to the implementation of social prescribing in the United Kingdom.Frontiers in health services · 2024Article
- Targeted health promotion with guided nature walks or group exercise: a controlled trial in primary care.Frontiers in public health · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Social prescribing (SP) is a mechanism to link patients with community groups and third sector organizations. It offers a complimentary approach to the traditional medical models to address psychosocial needs of patients more effectively and in turn aims to reduce demand on the NHS. The aim of this study was to explore the economic benefits related to changes in the use of healthcare resources following a social prescribing intervention in four primary care practices in Wales. Methods: Quantitative data from routine healthcare usage was collected from the 78 participants pre and post-intervention. The participants were grouped into frequent attenders (FA) ( Results: The SP as an intervention generated the largest cost saving for FAs. The cost variance when FAs participated in the intervention shows there is a direct cost saving of £6,113 or £78.37 per participant over the 5 months of the intervention. Conclusions: Results suggest there may be a cost saving associated with SP interventions, however caution should be exercised in interpreting the results due to the lack of control group in this study The cost saving were largest for FAs, where the intervention reduced healthcare unit usage as well as actual and inferred impact on associated healthcare costs. This suggests that in practice to generate the maximum cost benefit SP interventions could be targeted at FAs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.